Insider Transactions in Q3 2025 at Amneal Pharmaceuticals, Inc. (AMRX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2025
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Open market or private sale
|
Direct |
219,159
-64.21%
|
$1,972,431
$9.43 P/Share
|
|
Aug 14
2025
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Open market or private sale
|
Direct |
119,206
-25.89%
|
$1,072,854
$9.3 P/Share
|
|
Aug 14
2025
|
Nikita Shah Executive Vice President |
SELL
Open market or private sale
|
Direct |
71,694
-21.15%
|
$645,246
$9.29 P/Share
|
|
Aug 13
2025
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Open market or private sale
|
Direct |
161,365
-25.95%
|
$1,452,285
$9.22 P/Share
|
|
Aug 12
2025
|
Nikita Shah Executive Vice President |
SELL
Open market or private sale
|
Direct |
50,000
-12.86%
|
$450,000
$9.04 P/Share
|
|
Aug 12
2025
|
Andrew S Boyer Executive Vice President |
SELL
Open market or private sale
|
Direct |
33,436
-11.53%
|
$300,924
$9.05 P/Share
|
|
Aug 12
2025
|
Jason B. Daly EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
22,000
-67.47%
|
$198,000
$9.05 P/Share
|